Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress.

Animals Blotting, Western Cell Line Cell Survival / physiology Hydroxyl Radical / metabolism Iron / metabolism MAP Kinase Signaling System / physiology Male Mice Mice, Inbred C57BL Muscle Development / physiology Muscle, Skeletal / metabolism Oxidative Stress / physiology RNA, Messenger / metabolism Thiobarbituric Acid Reactive Substances / metabolism
ERK1/2 muscle differentiation muscle regeneration p38MAPK

Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 31 5 2019
medline: 2 6 2020
entrez: 31 5 2019
Statut: ppublish

Résumé

Skeletal muscle atrophy is caused by disruption in the homeostatic balance of muscle degeneration and regeneration under various pathophysiological conditions. We have previously reported that iron accumulation induces skeletal muscle atrophy

Identifiants

DOI: 10.1096/fj.201802724RR PMID: 31145863
pubmed: 31145863
doi: 10.1096/fj.201802724RR
doi:

Substances chimiques

RNA, Messenger 0
Thiobarbituric Acid Reactive Substances 0
Hydroxyl Radical 3352-57-6
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9551-9564

Auteurs

Yasumasa Ikeda (Y)

Department of Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Akiho Satoh (A)

Department of Medical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Yuya Horinouchi (Y)

Department of Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Hirofumi Hamano (H)

Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.

Hiroaki Watanabe (H)

Department of Clinical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Mizuki Imao (M)

Department of Medical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Masaki Imanishi (M)

Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.

Yoshito Zamami (Y)

Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Department of Clinical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Kenshi Takechi (K)

Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.

Yuki Izawa-Ishizawa (Y)

Department of Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Licht Miyamoto (L)

Department of Medical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Tasuku Hirayama (T)

Laboratory of Pharmaceutical and Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.

Hideko Nagasawa (H)

Laboratory of Pharmaceutical and Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.

Keisuke Ishizawa (K)

Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Department of Clinical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Ken-Ichi Aihara (KI)

Department of Community Medicine for Diabetes and Metabolic Disorders, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Koichiro Tsuchiya (K)

Department of Medical Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Toshiaki Tamaki (T)

Department of Pharmacology, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Techniques d'investigation › Techniques de sonde moléculaire › Dosage immunologique › Immunotransfert › Technique de Western › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Cellules › Cellules cultivées › Lignée cellulaire › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Survie cellulaire › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Produits chimiques inorganiques › Radical hydroxyle › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Fer › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Système de signalisation des MAP kinases › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Développement locomoteur › Développement musculaire › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Tissus › Muscles › Muscle strié › Muscles squelettiques › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Phénomènes physiologiques › Stress physiologique › Stress oxydatif › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN messager › Iron accumulation causes impaired myogenesis...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Substances réactives à l'acide thiobarbiturique › Iron accumulation causes impaired myogenesis...